Hence, deregulation of eNOS signaling and endothelial dysfunction in hypertensive disorders, associated with elevated 20-HETE levels, could be reduced via potent inhibition of CYP1B1 by TMS [5,6,7,8]. Here, CYP1B1 is linked to hypertensive disorder.